Research Article

ROS-Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment

Figure 5

The correction between TIME and ROS score. (a, b) The expression of 22 immune cells in cluster1/2 and high/low-risk groups. (c, d) The expression of six immune markers in cluster1/2 and high/low-risk groups. (e) The correlation between TIME and ROS score. , , , and .
(a)
(b)
(c)
(d)
(e)